IF
GNOM icon

Intrua Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Intrua Financial’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,747
Closed -$288K – 339
2022
Q3 		$288K Buy
+5,747
New +$324K 0.08% 235

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Intrua Financial's GNOM Position: Q4 2022 in Review

Intrua Financial sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2022, closing a stake of 5,747 shares — an estimated $288K sold.

Intrua Financial first reported a position in GNOM in Q3 2022 and held it in 1 quarter. The position peaked at $288K in Q3 2022. 64 funds tracked by Wall St. Rank hold GNOM as of Q4 2022.

  • Intrua Financial reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
  • Intrua Financial sold 5,747 Global X Genomics & Biotechnology ETF shares in Q4 2022, an estimated $288K.
  • Intrua Financial first reported a position in Global X Genomics & Biotechnology ETF in Q3 2022 and held it in 1 quarter.
  • Intrua Financial's Global X Genomics & Biotechnology ETF position peaked at $288K in Q3 2022.
  • 64 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2022.

Based on Intrua Financial's 13F filing for Q4 2022, filed 20 Jan 2023.